Risk of Herpes Zoster Ophthalmicus Recurrence After Recombinant Zoster Vaccination

眼带状疱疹 医学 接种疫苗 皮肤病科 木瓦 病毒学 外科 病毒
作者
Anushka Walia,Yu Sun,Nisha R. Acharya
出处
期刊:JAMA Ophthalmology [American Medical Association]
标识
DOI:10.1001/jamaophthalmol.2023.6830
摘要

Importance The recombinant zoster vaccine (RZV) is currently recommended for immunocompetent adults aged 50 years or older and immunocompromised adults aged 19 years or older and is effective in preventing herpes zoster ophthalmicus (HZO). However, questions about the safety of RZV in patients with a history of HZO remain. Objective To evaluate whether there is an increased risk of HZO recurrence after RZV in patients with a history of HZO. Design, Setting, and Participants This retrospective cohort study used medical and outpatient pharmacy claims data for commercial and Medicare Advantage enrollees from the Optum Labs Data Warehouse. Patients with incident HZO from January 1, 2010, to December 31, 2021, were identified; the study period ended on March 31, 2022. The vaccinated group consisted of patients with at least 1 dose of RZV more than 90 days following the initial HZO diagnosis. The unvaccinated group consisted of patients without any record of RZV in the study period. Vaccinated and unvaccinated patients were matched using exact k:1 matching without replacement. Exposure Recombinant zoster vaccination. Main Outcomes and Measures The main outcome was the number of HZO recurrences with and without RZV exposure. Results A total of 16 408 patients were included in the matched analysis, of whom 12 762 were unvaccinated (7806 [61.2%] female; mean [SD] age at diagnosis, 68.8 [10.3] years) and 3646 were vaccinated (2268 [62.2%] female; mean [SD] age at diagnosis, 67.4 [9.8] years). Within the primary risk period of 56 days after the index date (ie, the start of follow-up for the outcome), the incidence of HZO recurrence after any RZV exposure was 37.7 per 1000 person-years compared with 26.2 per 1000 person-years in the unexposed group. After controlling for race and ethnicity, inpatient stays, emergency department visits, concomitant vaccines, and eye care practitioner visits, the association between vaccination status and HZO exacerbation in the primary risk period had an adjusted hazard ratio for any RZV exposure of 1.64 (95% CI, 1.01-2.67; P = .04). Conclusions and Relevance In this study, RZV exposure was associated with a higher likelihood of HZO recurrence in patients with a history of HZO compared with no RZV exposure. These findings support consideration that patients with a history of HZO may benefit from monitoring after receiving RZV in case of HZO recurrence.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
果宝特攻完成签到 ,获得积分10
4秒前
不会游泳的鱼完成签到 ,获得积分10
8秒前
江月年完成签到 ,获得积分10
10秒前
大方的火龙果完成签到 ,获得积分10
13秒前
感动白开水完成签到,获得积分10
19秒前
郑洲完成签到 ,获得积分10
23秒前
罗实完成签到 ,获得积分10
24秒前
24秒前
30秒前
35秒前
丰富梦容发布了新的文献求助10
36秒前
42秒前
51秒前
mike2012完成签到 ,获得积分10
54秒前
56秒前
开放道天发布了新的文献求助10
57秒前
赛赛完成签到 ,获得积分10
58秒前
foyefeng完成签到,获得积分10
1分钟前
哈哈哈哈嘻嘻嘻完成签到 ,获得积分10
1分钟前
木槿花难开完成签到,获得积分10
1分钟前
雪山飞龙完成签到,获得积分10
1分钟前
我是老大应助开放道天采纳,获得10
1分钟前
Xzmmmm完成签到,获得积分10
1分钟前
优秀的牛青完成签到 ,获得积分10
1分钟前
XDM完成签到 ,获得积分10
1分钟前
第3行星完成签到 ,获得积分10
1分钟前
刻苦的新烟完成签到 ,获得积分10
1分钟前
haochi完成签到,获得积分10
1分钟前
胡萝卜佳完成签到 ,获得积分10
1分钟前
啦啦啦完成签到,获得积分10
1分钟前
CCsouljump完成签到 ,获得积分10
1分钟前
daisy完成签到 ,获得积分10
1分钟前
小静完成签到 ,获得积分10
1分钟前
丰富梦容完成签到 ,获得积分20
1分钟前
开放道天完成签到 ,获得积分10
1分钟前
CipherSage应助科研通管家采纳,获得10
1分钟前
微雨若,,完成签到 ,获得积分10
1分钟前
纯真追命完成签到 ,获得积分10
1分钟前
Dawn完成签到 ,获得积分10
1分钟前
杨永佳666完成签到 ,获得积分10
1分钟前
高分求助中
좌파는 어떻게 좌파가 됐나:한국 급진노동운동의 형성과 궤적 2500
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Cognitive linguistics critical concepts in linguistics 800
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
氟盐冷却高温堆非能动余热排出性能及安全分析研究 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3052652
求助须知:如何正确求助?哪些是违规求助? 2709874
关于积分的说明 7418267
捐赠科研通 2354453
什么是DOI,文献DOI怎么找? 1246090
科研通“疑难数据库(出版商)”最低求助积分说明 605951
版权声明 595921